(S)-tert-butyl 6-(5-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate(CAS: 1441670-89-8)

This compound (CAS: 1441670-89-8) falls under the scope of several regulatory guidelines. It is subject to REACH in the EU, which requires manufacturers and importers to register substances with the European Chemicals Agency (ECHA). In the US, it would be regulated by the EPA, and it should comply with FDA requirements for chemical substances. It is also important to adhere to GHS classification and labeling requirements for transport and storage.

Alternative reagents and compounds, such as similar azaspiro compounds with different substituents, can be used as alternatives. For instance, other fluorene-based intermediates or different azabicycles can serve as viable alternatives in the synthesis process. It is crucial to consider the specific reactivity and functional groups of the compound when selecting alternatives.

The research trend for this compound (CAS: 1441670-89-8) is focused on its potential applications in medicinal chemistry and organic synthesis. It is often used as a key intermediate in the development of complex organic molecules. Market trends indicate increasing interest in novel chemical structures for drug discovery and synthetic methodologies.

Waste containing this compound (CAS: 1441670-89-8) should be collected and managed according to local and national hazardous waste regulations. Professional waste disposal services should be used for incineration or chemical neutralization to ensure environmental protection. It is important to follow safety precautions and proper handling procedures to prevent contamination and ensure compliance with environmental standards.